Search Results 41-50 of 27087 for obesidad
"What we need to know about taking any intervention for obesity, including these two new medications, is that they're not a quick fix. They're.
Some studies have indicated that certain genetic changes within the TCF7L2 gene cause slight differences in risk of diabetes. He has requested samples from ...
A second class of drugs that may lead to weight loss and improved blood sugar control is the sodium glucose cotransporter 2 (SGLT-2) inhibitors. These include ...
Subscribe to updates. Quarterly publication for physicians that highlights trends in endocrinology-related procedures and disease management strategies at ...
About this study. The objectives of this study are to identify circulating extracellular vesicle (EV)-derived protein and RNA signatures associated with ...
The main risk for developing Type 2 diabetes is being overweight. Being inactive and having a family history also elevates your risk.
About this study. The purpose of the study is to conduct qualitative interviews of participants in a sleep restriction study who were allowed free snacking ...
A lifestyle intervention will be provided. These consist of an obesity physician consult, a low-calorie diet instructed by registered dietitians & nutritionists ...
Researchers also investigate mechanisms responsible for abnormal glucose metabolism in people with diabetes and prediabetes. Research can help find out the ...
DEAR MAYO CLINIC: I am a 42-year-old woman of Hispanic descent. At my annual physical, my clinician suggested I be screened for diabetes. I was surprised.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.